SCHEMBL18417846

SCHEMBL18417846

c1ccc(-c2ccc(N(c3ccc(-c4cccc(N(c5ccccc5)c5ccccc5)c4)cc3)c3ccc(-c4cccc(N(c5ccccc5)c5ccccc5)c4)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ MGLL Q99685 2/20 0.43
▸ MAOA P21397 1/20 0.43
▸ APP P05067 1/20 0.42
▸ ALOX5 P09917 1/20 0.41
▸ ACMSD Q8TDX5 2/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ CRHBP P24387 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ CRHR2 Q13324 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18680566 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL18680560 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL22355482 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL24309151 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL7900225 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL23108823 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL18417842 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL23108813 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL21365004 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E
SCHEMBL18417854 1.00 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP3A4CYP2C9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170033289-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-02 — — US disclosed
US-20170033289-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170033289-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME L1CAM, TELO2, EPCAM ALDH1A1 499/4885L3MBTL1 26/4885CYP3A4 3456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback